node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ADIPOQ | ADIPOR2 | ENSECAP00000002024 | ENSECAP00000044374 | Adiponectin, C1Q and collagen domain containing. | Adiponectin receptor 2. | 0.999 |
ADIPOQ | APLN | ENSECAP00000002024 | ENSECAP00000038395 | Adiponectin, C1Q and collagen domain containing. | Uncharacterized protein. | 0.591 |
ADIPOQ | IL1B | ENSECAP00000002024 | ENSECAP00000053627 | Adiponectin, C1Q and collagen domain containing. | Interleukin-1 beta; Potent proinflammatory cytokine. Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B- cell activation and antibody production, and fibroblast proliferation and collagen production. Promotes Th17 differentiation of T-cells. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T- helper 1 (Th1) cells. | 0.622 |
ADIPOQ | IL6 | ENSECAP00000002024 | ENSECAP00000014219 | Adiponectin, C1Q and collagen domain containing. | Interleukin-6; Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. Required for the generation of T(H)17 cells. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance. It induces myeloma and plasm [...] | 0.787 |
ADIPOQ | INS | ENSECAP00000002024 | ENSECAP00000022114 | Adiponectin, C1Q and collagen domain containing. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.945 |
ADIPOQ | LEP | ENSECAP00000002024 | ENSECAP00000035337 | Adiponectin, C1Q and collagen domain containing. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.980 |
ADIPOQ | NAMPT | ENSECAP00000002024 | ENSECAP00000025907 | Adiponectin, C1Q and collagen domain containing. | Nicotinamide phosphoribosyltransferase; Belongs to the NAPRTase family. | 0.551 |
ADIPOQ | RETN | ENSECAP00000002024 | ENSECAP00000013951 | Adiponectin, C1Q and collagen domain containing. | Resistin. | 0.950 |
ADIPOQ | TNF | ENSECAP00000002024 | ENSECAP00000001460 | Adiponectin, C1Q and collagen domain containing. | Tumor necrosis factor, membrane form; Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation (By similarity). Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces [...] | 0.685 |
ADIPOR2 | ADIPOQ | ENSECAP00000044374 | ENSECAP00000002024 | Adiponectin receptor 2. | Adiponectin, C1Q and collagen domain containing. | 0.999 |
ADIPOR2 | INS | ENSECAP00000044374 | ENSECAP00000022114 | Adiponectin receptor 2. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.610 |
ADIPOR2 | LEP | ENSECAP00000044374 | ENSECAP00000035337 | Adiponectin receptor 2. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.760 |
ADIPOR2 | NAMPT | ENSECAP00000044374 | ENSECAP00000025907 | Adiponectin receptor 2. | Nicotinamide phosphoribosyltransferase; Belongs to the NAPRTase family. | 0.503 |
ADIPOR2 | RETN | ENSECAP00000044374 | ENSECAP00000013951 | Adiponectin receptor 2. | Resistin. | 0.688 |
APLN | ADIPOQ | ENSECAP00000038395 | ENSECAP00000002024 | Uncharacterized protein. | Adiponectin, C1Q and collagen domain containing. | 0.591 |
APLN | INS | ENSECAP00000038395 | ENSECAP00000022114 | Uncharacterized protein. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.631 |
APLN | LEP | ENSECAP00000038395 | ENSECAP00000035337 | Uncharacterized protein. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.560 |
APLN | RETN | ENSECAP00000038395 | ENSECAP00000013951 | Uncharacterized protein. | Resistin. | 0.658 |
ARG1 | IL1B | ENSECAP00000021081 | ENSECAP00000053627 | Arginase. | Interleukin-1 beta; Potent proinflammatory cytokine. Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B- cell activation and antibody production, and fibroblast proliferation and collagen production. Promotes Th17 differentiation of T-cells. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T- helper 1 (Th1) cells. | 0.823 |
ARG1 | IL6 | ENSECAP00000021081 | ENSECAP00000014219 | Arginase. | Interleukin-6; Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. Required for the generation of T(H)17 cells. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance. It induces myeloma and plasm [...] | 0.927 |